JCPB | OACP | JCPB / OACP | |
Gain YTD | 3.614 | 3.047 | 119% |
Net Assets | 6.09B | 164M | 3,710% |
Total Expense Ratio | 0.38 | 0.74 | 51% |
Turnover | 57.00 | 197.00 | 29% |
Yield | 5.05 | 4.55 | 111% |
Fund Existence | 6 years | 3 years | - |
JCPB | OACP | |
---|---|---|
RSI ODDS (%) | 1 day ago47% | 1 day ago42% |
Stochastic ODDS (%) | 1 day ago43% | 1 day ago53% |
Momentum ODDS (%) | 1 day ago54% | 1 day ago61% |
MACD ODDS (%) | 1 day ago50% | 1 day ago52% |
TrendWeek ODDS (%) | 1 day ago53% | 1 day ago61% |
TrendMonth ODDS (%) | 1 day ago52% | 1 day ago54% |
Advances ODDS (%) | 4 days ago52% | 1 day ago58% |
Declines ODDS (%) | 9 days ago48% | 9 days ago51% |
BollingerBands ODDS (%) | 1 day ago48% | 1 day ago46% |
Aroon ODDS (%) | 1 day ago41% | 1 day ago49% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
DRV | 28.27 | 2.39 | +9.23% |
Direxion Daily Real Estate Bear 3X ETF | |||
PDO | 13.77 | -0.06 | -0.43% |
PIMCO Dynamic Income Opportunities Fund | |||
FMF | 46.01 | -0.43 | -0.92% |
First Trust Managed Future Strategy ETF | |||
IBRN | 20.94 | -0.86 | -3.93% |
iShares Neuroscience and Healthcare ETF | |||
SMOT | 31.03 | -2.21 | -6.65% |
VanEck Morningstar SMID Moat ETF |
A.I.dvisor tells us that JCPB and EXE have been poorly correlated (+6% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that JCPB and EXE's prices will move in lockstep.
Ticker / NAME | Correlation To JCPB | 1D Price Change % | ||
---|---|---|---|---|
JCPB | 100% | +0.47% | ||
EXE - JCPB | 6% Poorly correlated | -2.92% | ||
DAKT - JCPB | 2% Poorly correlated | -7.77% | ||
CHRD - JCPB | -1% Poorly correlated | -12.38% |